These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 34773483)
1. Abuse and dependence potential of sphingosine-1-phosphate (S1P) receptor modulators used in the treatment of multiple sclerosis: a review of literature and public data. Schoedel KA; Kolly C; Gardin A; Neelakantham S; Shakeri-Nejad K Psychopharmacology (Berl); 2022 Jan; 239(1):1-13. PubMed ID: 34773483 [TBL] [Abstract][Full Text] [Related]
2. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives. Bravo GÁ; Cedeño RR; Casadevall MP; Ramió-Torrentà L Cells; 2022 Jun; 11(13):. PubMed ID: 35805142 [TBL] [Abstract][Full Text] [Related]
4. Sphingosine 1-phosphate receptor modulators in multiple sclerosis treatment: A practical review. Coyle PK; Freedman MS; Cohen BA; Cree BAC; Markowitz CE Ann Clin Transl Neurol; 2024 Apr; 11(4):842-855. PubMed ID: 38366285 [TBL] [Abstract][Full Text] [Related]
5. An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis. Dumitrescu L; Papathanasiou A; Coclitu C; Garjani A; Evangelou N; Constantinescu CS; Popescu BO; Tanasescu R Expert Opin Pharmacother; 2023 Mar; 24(4):495-509. PubMed ID: 36946625 [TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects. Chun J; Giovannoni G; Hunter SF Drugs; 2021 Feb; 81(2):207-231. PubMed ID: 33289881 [TBL] [Abstract][Full Text] [Related]
7. Sphingosine 1-Phosphate Receptor Modulators for Multiple Sclerosis. Roy R; Alotaibi AA; Freedman MS CNS Drugs; 2021 Apr; 35(4):385-402. PubMed ID: 33797705 [TBL] [Abstract][Full Text] [Related]
8. The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination. Baker D; Forte E; Pryce G; Kang AS; James LK; Giovannoni G; Schmierer K Mult Scler Relat Disord; 2023 Jan; 69():104425. PubMed ID: 36470168 [TBL] [Abstract][Full Text] [Related]
9. A comprehensive review of varicella-zoster virus, herpes simplex virus and cryptococcal infections associated with sphingosine-1-phosphate receptor modulators in multiple sclerosis patients. Sharma K; Chaudhary D; Beard K; Srivastava S; Khalid SH; Sriwastava S Mult Scler Relat Disord; 2022 Mar; 59():103675. PubMed ID: 35168095 [TBL] [Abstract][Full Text] [Related]
10. Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions. McGinley MP; Cohen JA Lancet; 2021 Sep; 398(10306):1184-1194. PubMed ID: 34175020 [TBL] [Abstract][Full Text] [Related]
11. Competitive Binding of Ozanimod and Other Sphingosine 1-Phosphate Receptor Modulators at Receptor Subtypes 1 and 5. Selkirk JV; Bortolato A; Yan YG; Ching N; Hargreaves R Front Pharmacol; 2022; 13():892097. PubMed ID: 35784713 [TBL] [Abstract][Full Text] [Related]
12. Patients' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment. Keenan A; Whichello C; Le HH; Kern DM; Fernandez GS; Turner V; Das A; Quaife M; Ross AP Patient; 2024 Nov; 17(6):685-696. PubMed ID: 38748388 [TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate receptor modulators in stroke treatment. Zhang W; Li Y; Li F; Ling L J Neurochem; 2022 Sep; 162(5):390-403. PubMed ID: 35943290 [TBL] [Abstract][Full Text] [Related]
14. Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5. Selkirk JV; Dines KC; Yan YG; Ching N; Dalvie D; Biswas S; Bortolato A; Schkeryantz JM; Lopez C; Ruiz I; Hargreaves R J Pharmacol Exp Ther; 2021 Dec; 379(3):386-399. PubMed ID: 34535564 [TBL] [Abstract][Full Text] [Related]
15. S1P receptor modulators in Multiple Sclerosis: Detecting a potential skin cancer safety signal. Stamatellos VP; Rigas A; Stamoula E; Lallas A; Papadopoulou A; Papazisis G Mult Scler Relat Disord; 2022 Mar; 59():103681. PubMed ID: 35168096 [TBL] [Abstract][Full Text] [Related]